Urotensin II activates sarcolemmal Na+/H+ exchanger in adult rat ventricular myocytes

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 2, 2010, Pages 191-197

  Kato, Koji ^a   Yasutake, Masahiro ^a   Jia, Dalin ^b   Snabaitis, Andrew K ^c   Avkiran, Metin ^c   Kusama, Yoshiki ^a   Takano, Teruo ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Extracellular signal regulated kinase 1 2; G protein coupled receptor; Protein kinase C; Urotensin II

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; AMMONIUM CHLORIDE; DIPHENYLCARBAMIC ACID 4 CARBOXY 2 NITROPHENYL ESTER; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C; PROTEIN KINASE C; SODIUM PROTON EXCHANGE PROTEIN; UROTENSIN II; UROTENSIN;

ANIMAL CELL; ARTICLE; CELL PH; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE FIBER MEMBRANE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; AGE; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; ENZYMOLOGY; HEART MUSCLE CELL; HEART VENTRICLE; HUMAN; METABOLISM; PHYSIOLOGY; SARCOLEMMA; SPRAGUE DAWLEY RAT;

AGE FACTORS; ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEART VENTRICLES; HUMANS; MALE; MYOCYTES, CARDIAC; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SARCOLEMMA; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; TYPE C PHOSPHOLIPASES; UROTENSINS;

EID: 77649287538     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181cf0074     Document Type: Article

References (36)

1. Leem CH, Lagadic-Gossmann D, Vaughan-Jones RD. Characterization of intracellular pH regulation in the guinea-pig ventricular myocyte. J Physiol. 1999;517:159-180.
2. Avkiran M, Marber MS. Na+/H+ exchange inhibitors for cardioprotective therapy: Progress, problems and prospects. J Am Coll Cardiol. 2002;39: 747-753.
3. Karmazyn M, Kilic A, Javadov S. The role of NHE-1 in myocardial hypertrophy and remodelling. J Mol Cell Cardiol. 2008;44:647-653.
4. Karmazyn M, Gan XT, Humphreys RA, et al. The myocardial Na+-H+ exchange: structure, regulation, and its role in heart disease. Circ Res. 1999;85:777-786.
5. Takewaki S, Kuro-o M, Hiroi Y, et al. Activation of Na+-H+ antiporter (NHE-1) gene expression during growth, hypertrophy and proliferation of the rabbit cardiovascular system. J Mol Cell Cardiol. 1995;27:729-742.
6. Engelhardt S, Hein L, Keller U, et al. Inhibition of Na+-H+ exchange prevents hypertrophy, fibrosis, and heart failure in b1-adrenergic receptor transgenic mice. Circ Res. 2002;90:814-819.
7. Baartscheer A, Schumacher CA, Van Borren MM, et al. Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. Cardiovasc Res. 2005;65:83-92.
8. Avkiran M. Protection of the ischaemic myocardium by Na+/H+ exchange inhibitors: Potential mechanisms of action. Basic Res Cardiol. 2001;96: 306-311.
9. Avkiran M. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol. 1999;83:G10-G17.
10. Avkiran M, Haworth RS. Regulatory effects of G protein-coupled receptors on cardiac sarcolemmal Na+/H+ exchanger activity: signalling and significance. Cardiovasc Res. 2003;57:942-952.
11. Howard AD, McAllister G, Feighner SD, et al. Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol Sci. 2001;22: 132-140.
12. Bern HA, Pearson D, Larson BA, et al. Neurohormones from fish tails: The caudal neurosecretory system. I. ''Urophysiology'' and the caudal neurosecretory system of fishes. Recent Prog Horm Res. 1985;41:533-552.
13. Douglas SA, Ohlstein EH. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med. 2000; 10:229-237.
14. Zhu YC, Zhu YZ, Moore PK. The role of urotensin II in cardiovascular and renal physiology and diseases. Br J Pharmacol. 2006;148:884-901.
15. Russell FD, Molenaar P, O'Brien DM. Cardiostimulant effects of urotensin-II in human heart in vitro. Br J Pharmacol. 2001;132:5-9.
16. Gong H,Wang YX, Zhu YZ, et al. Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat. J Appl Physiol. 2004;97:2228-2235.
17. Yasutake M, Haworth RS, King A, et al. Thrombin activates the sarcolemmal Na+-H+ exchanger. Evidence for a receptor-mediated mechanism involving protein kinase C. Circ Res. 1996;79:705-715.
18. Yokoyama H, Yasutake M, Avkiran M. a1-Adrenergic stimulation of sarcolemmal Na+-H+ exchanger activity in rat ventricular myocytes: evidence for selective mediation by the a1A-adrenoceptor subtype. Circ Res. 1998;82:1078-1085.
19. Snabaitis AK, Yokoyama H, Avkiran M. Roles of mitogen-activated protein kinases and protein kinase C in a1A-adrenoceptor-mediated stimulation of the sarcolemmal Na+-H+ exchanger. Circ Res. 2000;86:214-220.
20. Saetrum Opgaard O, Nothacker H, Ehlert FJ, et al. Human urotensin II mediates vasoconstriction via an increase in inositol phosphates. Eur J Pharmacol. 2000;406:265-271.
21. Toullec D, Pianetti P, Coste H, et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266:15771-15781.
22. Moor AN, Fliegel L. Protein kinase-mediated regulation of the Na+/H+ exchanger in the rat myocardium by mitogen-activated protein kinasedependent pathways. J Biol Chem. 1999;274:22985-22992.
23. Douglas SA. Human urotensin-II as a novel cardiovascular target:'Heart' of the matter or simply a fishy-tail'? Curr Opin Pharmacol. 2003;3:159-167.
24. Russell FD, Molenaar P. Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart. Cardiovasc Res. 2004; 63:673-681.
25. Onan D, Pipolo L, Yang E, et al. Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases. Mol Endocrinol. 2004;18:2344-2354.
26. Tzanidis A, Hannan RD, Thomas WG, et al. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Circ Res. 2003;93:246-253.
27. Zou Y, Nagai R, Yamazaki T. Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats. FEBS Lett. 2001;508:57-60.
28. Fliegel L. Regulation of myocardial Na+/H+ exchanger activity. Basic Res Cardiol. 2001;96:301-305.
29. Snabaitis AK, Hearse DJ, Avkiran M. Regulation of sarcolemmal Na+/H+ exchange by hydrogen peroxide in adult rat ventricular myocytes. Cardiovasc Res. 2002;53:470-480.
30. Gunasegaram S, Haworth RS, Hearse DJ, et al. Regulation of sarcolemmal Na+/H+ exchanger activity by angiotensin II in adult rat ventricular myocytes: opposing actions via AT1 versus AT2 receptors. Circ Res. 1999; 85:919-930.
31. Endoh M, Fujita S, Yang HT, et al. Endothelin: Receptor subtypes, signal transduction, regulation of Ca2+ transients and contractility in rabbit ventricular myocardium. Life Sci. 1998;62:1485-1489.
32. Wallert MA, Frohlich O. a1-Adrenergic stimulation of Na-H exchange in cardiac myocytes. Am J Physiol. 1992;263:C1096-C1102.
33. Smith JA, Poteet-Smith CE, Malarkey K, et al. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem. 1999;274:2893-2898.
34. Maguire JJ, Kuc RE, Kleinz MJ, et al. Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: Relevance to function. Peptides. 2008;29:735-742.
35. Alessi DR, Cuenda A, Cohen P, et al. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995;270:27489-27494.
36. Behm DJ, Harrison SM, Ao Z, et al. Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice. Br J Pharmacol. 2003;139: 464-472.